Narre相关文献与解析，生知库 | 链接生命科学的每一步

Aiello Bowles, Erin J; O'Connell, Kelli; Bhimani, Jenna; Gallagher, Grace B; Blinder, Victoria S; Doud, Rachael Burganowski; Ergas, Isaac J; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Persaud, Sonia; Rivera, Donna R; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Wang, Peng; Bandera, Elisa V; Kushi, Lawrence H; Kantor, Elizabeth D

肿瘤

肿瘤免疫

乳腺癌

发表日期：2026

文献求助收藏

Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer

与I-IIIA期乳腺癌化疗剂量减少相关的临床医生和医疗机构层面的因素

期刊:Jnci-Journal of the National Cancer Institute

影响因子:7.2

doi:10.1093/jnci/djag063

Sampathkumar, Yashasvini; Zakaria, Ziad; O'Connell, Kelli; Bhimani, Jenna; Blinder, Victoria S; Burganowski, Rachael; Ergas, Isaac J; Gallagher, Grace B; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Monroy-Iglesias, Maria J; Nakata, Kanichi G; Persaud, Sonia; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Wang, Peng; Bandera, Elisa V; Aiello Bowles, Erin J; Kushi, Lawrence H; Kantor, Elizabeth D

Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings

在真实世界环境中评估识别化疗相关血液毒性的方法

期刊:International Journal of Cancer

影响因子:4.7

doi:10.1002/ijc.70266

Wang, Peng; O'Connell, Kelli; Bhimani, Jenna; Blinder, Victoria; Burganowski, Rachael; Ergas, Isaac J; Gallagher, Grace B; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Persaud, Sonia; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Sampathkumar, Yashasvini; Monroy-Iglesias, Maria J; Bandera, Elisa V; Kushi, Lawrence H; Kantor, Elizabeth D; Aiello Bowles, Erin J

毒理研究

发表日期：2026

文献求助收藏

Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer

了解体重指数与接受 I-IIIA 期乳腺癌治疗的女性化疗剂量减少之间的关系

期刊:NPJ Breast Cancer

影响因子:7.6

doi:10.1038/s41523-025-00833-9

Bhimani, Jenna; O'Connell, Kelli; Gallagher, Grace B; Blinder, Victoria S; Burganowski, Rachael; Ergas, Isaac J; Griggs, Jennifer J; Heon, Narre; Jinna, Sankeerth; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Persaud, Sonia; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Wang, Peng; Bandera, Elisa V; Aiello Bowles, Erin J; Kushi, Lawrence H; Kantor, Elizabeth D

Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer

临床医生和医疗机构层面的因素与I-IIIA期乳腺癌女性接受非指南化疗方案相关

期刊:Jco Oncology Practice

影响因子:4.6

doi:10.1200/OP-25-00086

Sampathkumar, Yashasvini; Zakaria, Ziad; O'Connell, Kelli; Bhimani, Jenna; Blinder, Victoria S; Burganowski, Rachael; Ergas, Isaac J; Gallagher, Grace B; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Persaud, Sonia; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Bandera, Elisa V; Aiello Bowles, Erin J; Kushi, Lawrence H; Kantor, Elizabeth D

Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer

I-IIIA期乳腺癌女性患者接受常规化疗方案与高剂量密集化疗方案的患者特征

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-025-07764-w

Bhimani, Jenna; Wang, Peng; Gallagher, Grace B; O'Connell, Kelli; Persaud, Sonia; Blinder, Victoria S; Burganowski, Rachael; Ergas, Isaac J; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Bandera, Elisa V; Aiello Bowles, Erin J; Kushi, Lawrence H; Kantor, Elizabeth D

Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study

癌症患者队列合并症定义的方法学方法：以最佳乳腺癌化疗剂量研究为例

期刊:JCO Clinical Cancer Informatics

影响因子:2.8

doi:10.1200/CCI-24-00231

Wang, Peng; O'Connell, Kelli; Bhimani, Jenna; Blinder, Victoria; Burganowski, Rachael; Ergas, Isaac J; Gallagher, Grace B; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Persaud, Sonia; Rivera, Donna R; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Bandera, Elisa V; Kushi, Lawrence H; Aiello Bowles, Erin J; Kantor, Elizabeth D

Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019

2006年至2019年早期乳腺癌化疗使用趋势

期刊:Breast Cancer Research

影响因子:5.6

doi:10.1186/s13058-024-01822-9

Bhimani, Jenna; O'Connell, Kelli; Ergas, Isaac J; Foley, Marilyn; Gallagher, Grace B; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Persaud, Sonia; Rivera, Donna R; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Bowles, Erin J A; Bandera, Elisa V; Kushi, Lawrence H; Kantor, Elizabeth D

Evaluation of Algorithms Using Automated Health Plan Data to Identify Breast Cancer Recurrences

利用自动化健康计划数据评估算法以识别乳腺癌复发

期刊:Cancer Epidemiology Biomarkers & Prevention

影响因子:3.4

doi:10.1158/1055-9965.EPI-23-0782

Aiello Bowles, Erin J; Kroenke, Candyce H; Chubak, Jessica; Bhimani, Jenna; O'Connell, Kelli; Brandzel, Susan; Valice, Emily; Doud, Rachael; Theis, Mary Kay; Roh, Janise M; Heon, Narre; Persaud, Sonia; Griggs, Jennifer J; Bandera, Elisa V; Kushi, Lawrence H; Kantor, Elizabeth D

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer

与I期至IIIA期乳腺癌女性患者计划接受非指南化疗相关的患者特征

期刊:Cancer Epidemiology Biomarkers & Prevention

影响因子:3.4

doi:10.1158/1055-9965.EPI-24-0360

Bhimani, Jenna; O'Connell, Kelli; Persaud, Sonia; Blinder, Victoria; Burganowski-Doud, Rachael P; Ergas, Isaac J; Gallagher, Grace B; Griggs, Jennifer J; Heon, Narre; Kolevska, Tatjana; Kotsurovskyy, Yuriy; Kroenke, Candyce H; Laurent, Cecile A; Liu, Raymond; Nakata, Kanichi G; Rivera, Donna R; Roh, Janise M; Tabatabai, Sara; Valice, Emily; Bandera, Elisa V; Aiello Bowles, Erin J; Kushi, Lawrence H; Kantor, Elizabeth D

Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

年龄与I-IIIA期乳腺癌女性化疗剂量减少之间的关联

Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer

与I-IIIA期乳腺癌化疗剂量减少相关的临床医生和医疗机构层面的因素

Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings

在真实世界环境中评估识别化疗相关血液毒性的方法

Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer

了解体重指数与接受 I-IIIA 期乳腺癌治疗的女性化疗剂量减少之间的关系

Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer

临床医生和医疗机构层面的因素与I-IIIA期乳腺癌女性接受非指南化疗方案相关

Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer

I-IIIA期乳腺癌女性患者接受常规化疗方案与高剂量密集化疗方案的患者特征

Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study

癌症患者队列合并症定义的方法学方法：以最佳乳腺癌化疗剂量研究为例

Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019

2006年至2019年早期乳腺癌化疗使用趋势

Evaluation of Algorithms Using Automated Health Plan Data to Identify Breast Cancer Recurrences

利用自动化健康计划数据评估算法以识别乳腺癌复发

Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer

与I期至IIIA期乳腺癌女性患者计划接受非指南化疗相关的患者特征